Director,BD
Ms.Changlan Zhu joined InxMed in August 2025 as Director of Business Development (BD). With over a decade of experience in the pharmaceutical industry, Ms.Changlan Zhu specializes in corporate strategy planning and pharmaceutical business development. She has previously held positions at multinational pharmaceutical companies including GlaxoSmithKline and Sumitomo Pharma, and possesses a global perspective, successful entrepreneurial experience, and a cross-disciplinary background in AI-driven drug discovery. Throughout her career, she has successfully incubated and executed five overseas collaboration projects, which subsequently secured investment from renowned investment institutions, and has led one cross-border M&A transaction. Ms.Changlan Zhu has extensive experience in pharmaceutical deal-making, resource integration, and commercial negotiations. Ms.Changlan Zhu holds a Bachelor of Science degree from the Enhanced Program in Biochemical Pharmacy at Nanjing University and a graduate degree from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.
Latest Products